Device typeAortic transcatheter heart valve bioprosthesis, stent-like framework: An implantable xenograft (e.g., bovine, porcine) intended to be used to repair/replace a stenosed and/or regurgitant aortic heart valve, or previously-implanted aortic heart valve prosthesis, and which is designed to be implanted with a catheter via transarterial access (e.g., femoral, subclavian, aortic) or transapical access while the heart is beating. It is comprised of the xenograft, processed to render the tissue non-viable, attached to an expandable metal framework, which is implanted with an included catheter, and when in situ, may be expanded with a balloon or self-expand. Typically devices associated with implantation (e.g., catheter, introducer) are included.
FDA categoryAortic Valve, Prosthesis, Percutaneously Delivered, Prosthesis, Mitral Valve, Percutaneously Delivered
Device ID00690103201185
Catalog number9630TA23A
Single useYes
SterileYes
MRI safetyMR Conditional
SizeOuter Diameter, 23 MM